Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its ...

When we tasted and ranked Great Value coffee creamers from worst to best, we found this bottom-ranking flavor to be such a ...

Ajanta is betting on its strong ground presence in these markets, increasing demand and assured supply from Biocon to gain significant share overseas. (Mint) As drugmakers race to prepare for the ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

SALT LAKE CITY — The Utah Department of Commerce's Division of Consumer Protection and the Utah Attorney General's Office have reached a settlement with global pharmaceutical company Sandoz Inc. in a ...

Wondering whether to opt for store brand or name-brand food at the grocery store? We have insider secrets to share! Should you spend the extra buck or two on that name-brand ketchup or just reach for ...

WASHINGTON, DC (Reuters) – President Donald Trump announced plans to impose a 25% or higher tariff on semiconductor and pharmaceutical imports, a move that could significantly impact India’s ...

・The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday. ・Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin ...

Canadians face a longer-than-expected wait for cheaper versions of Novo Nordisk A/S’s diabetes drug Ozempic after two of the biggest generics makers were hit with additional requests from the health ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable healthcare stocks to buy now. Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced on December 24 that S&P ...